Trials / Withdrawn
WithdrawnNCT04388722
Monitoring Noninvasively for Infusion and Transfusion Optimization
Monitoring Noninvasively for Infusion and Transfusion Optimization in a Randomized (MONITOR) Trial
- Status
- Withdrawn
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 0 (actual)
- Sponsor
- Masimo Corporation · Industry
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- Not accepted
Summary
This is a multicenter, cluster randomized controlled trial to assess the effects of an optimized intraoperative fluid and blood management strategy on postoperative complications.
Conditions
- Post Operative Hemorrhage
- Transfusion Related Complication
- Blood Transfusion Associated Adverse Reactions
- Hypovolemia
Interventions
| Type | Name | Description |
|---|---|---|
| DEVICE | Pulse CO-Oximeter Sensor | Investigational Pulse CO-Oximeter sensor will measure hemoglobin (SpHb) and pleth variability index (PVi). |
Timeline
- Start date
- 2020-06-01
- Primary completion
- 2020-12-01
- Completion
- 2020-12-01
- First posted
- 2020-05-14
- Last updated
- 2021-07-23
Regulatory
- FDA-regulated device study
Source: ClinicalTrials.gov record NCT04388722. Inclusion in this directory is not an endorsement.